What is the level of liabilities of Orion Oyj this year?
Orion Oyj has a debt balance of 548.5 M EUR this year.
Orion Oyj Liabilities 2024
Orion Oyj Liabilities
548.5 M EUR
Ticker
ORNBV.HE
ISIN
FI0009014377
WKN
A0J3QM
In 2024, Orion Oyj's total liabilities amounted to 548.5 M EUR, a -7.89% difference from the 595.5 M EUR total liabilities in the previous year.
Orion Oyj Aktienanalyse
What does Orion Oyj do?
Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Orion Oyj's Liabilities
Orion Oyj's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Orion Oyj's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Orion Oyj's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Orion Oyj's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Orion Oyj’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Orion Oyj stock
What were the liabilities of Orion Oyj compared to the previous year?
The liabilities of Orion Oyj have increased by -7.89% dropped compared to the previous year.
What are the consequences of high debt for investors of Orion Oyj?
High liabilities can pose a risk for investors of Orion Oyj, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Orion Oyj?
Low liabilities mean that Orion Oyj has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Orion Oyj affect the company?
An increase in liabilities of Orion Oyj can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Orion Oyj affect the company?
A decrease in the liabilities of Orion Oyj can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Orion Oyj?
Some factors that can influence the liabilities of Orion Oyj include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Orion Oyj so important for investors?
The liabilities of Orion Oyj are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Orion Oyj take to modify the liabilities?
To change its liabilities, Orion Oyj can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Orion Oyj pay?
Over the past 12 months, Orion Oyj paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 3.26 %. For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.73 EUR.
What is the dividend yield of Orion Oyj?
The current dividend yield of Orion Oyj is 3.26 %.
When does Orion Oyj pay dividends?
Orion Oyj pays a quarterly dividend. This is distributed in the months of April, April, April, November.
How secure is the dividend of Orion Oyj?
Orion Oyj paid dividends every year for the past 23 years.
What is the dividend of Orion Oyj?
For the upcoming 12 months, dividends amounting to 1.73 EUR are expected. This corresponds to a dividend yield of 3.54 %.
In which sector is Orion Oyj located?
Orion Oyj is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orion Oyj from 10/23/2024 amounting to 0.81 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Orion Oyj pay the last dividend?
The last dividend was paid out on 10/23/2024.
What was the dividend of Orion Oyj in the year 2023?
In the year 2023, Orion Oyj distributed 1.5 EUR as dividends.
In which currency does Orion Oyj pay out the dividend?
The dividends of Orion Oyj are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orion Oyj
Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
